Research and Technology

27.02.20

NICE recommends new treatment for follicular lymphoma

The National Institute for Health and Care Excellence (NICE) have published final draft guidance approving a new treatment option for patients with previously-treated follicular lymphoma (grade 1 to 3A).

The new drug, lenalidomide, fights cancer cells in a different way to currently available treatments, interfering with cell processes to halt the growth of tumours and stopping them from producing their own blood vessels.

As part of the guidance, NICE has recommended using lenalidomide alongside rituximab, an anti-CD20 antibody which sticks to cancer cells to help the immune system recognise and kill them. Rituximab is often used alongside chemotherapy as the standard treatment for follicular lymphoma, but it is thought around 1 in every 5 patients relapse from rituximab with chemotherapy within two years of treatment.

Meindert Boysen, Director of the Centre for Health Technology Evaluation at NICE, said: “Lenalidomide is a new type of targeted cancer therapy for people with previously treated follicular lymphoma. It not only offers patients a chemotherapy-free treatment option, but it also benefits those whose disease has become resistant to chemotherapy or rituximab.

“Lenalidomide fights cancer cells in a different way to current treatments which should help reduce resistance and improve disease outcomes.

“The use of lenalidomide with rituximab is more toxic to cancer cells than the singular use of either drug. Importantly, patients have also been seen to overcome previous resistance to rituximab when it’s taken with lenalidomide.

“We’re therefore pleased to be able to recommend the use of lenalidomide with rituximab on the NHS, as an alternative treatment for people with previously treated follicular lymphoma.”

READ MORE: NICE approves breast cancer drug combination on Cancer Drugs Fund

READ MORE: NICE impact report says better public awareness of lung cancer could save countless lives

Health Minister Jo Churchill added: ““This new drug offers cancer patients treatment which is free from the gruelling side effects of chemotherapy, as well as giving fresh hope to those who have built resistance to existing medicines.

“Revolutionary treatments such as this demonstrate how our NHS continues to push boundaries to ensure patients receive the best possible care as research develops.”

Clinical trial evidence shows that taking lenalidomide with rituximab increases the length of time before the disease progresses by around 39 months, compared to around 14 months when taking rituximab alone.

It is estimated around 900 people would be eligible for treatment.

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

NHS Business Services Authority: ‘We are the NHS supporting the NHS’

31/03/2020NHS Business Services Authority: ‘We are the NHS supporting the NHS’

With the ongoing coronavirus outbreak demanding significant time and care from the NHS, it has become vitally important for all aspects of the he... more >
Zappshelter: ‘It’s about supporting the country in a time of need’

31/03/2020Zappshelter: ‘It’s about supporting the country in a time of need’

[Sponsored Content] In light of the ongoing coronavirus outbreak, workforces have seen a need to keep people separated on sites, with specia... more >
NHSCFA: Never get bored of fraud

31/03/2020NHSCFA: Never get bored of fraud

Matthew Jordan-Boyd, Director of Finance & Corporate Governance, NHS Counter Fraud Authority (NHSCFA) I have written several articles ab... more >

editor's comment

25/09/2017A hotbed of innovation

This edition of NHE comes hot on the heels of this year’s NHS Expo which, once again, proved to be a huge success at Manchester Central. A number of announcements were made during the event, with the health secretary naming the second wave of NHS digital pioneers, or ‘fast followers’, which follow the initial global digital exemplars who were revealed at the same show 12 months earlier.  Jeremy Hunt also stated th... read more >

last word

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad: ‘We all have a role to play in getting innovations quicker’

Haseeb Ahmad, president of the Association of the British Pharmaceutical Industry (ABPI), sits down with National Health Executive as part of our Last Word Q&A series. Would you talk us th... more > more last word articles >

the scalpel's daily blog

NHSCFA: Never get bored of fraud

31/03/2020NHSCFA: Never get bored of fraud

Matthew Jordan-Boyd, Director of Finance & Corporate Governance, NHS Counter Fraud Authority (NHSCFA) I have written several articles about the work of NHSCFA and that tends to be from my fairly technical angle as a figures person, an accountant who has worked in the NHS for almost 20 years. When I discuss the need to be more vig... more >
read more blog posts from 'the scalpel' >

comment

NHS England dementia director prescribes rugby for mental health and dementia patients

23/09/2019NHS England dementia director prescribes rugby for mental health and dementia patients

Reason to celebrate as NHS says watching rugby can be good for your mental health and wellbeing. As the best rugby players in the world repr... more >
Peter Kyle MP: It’s time to say thank you this Public Service Day

21/06/2019Peter Kyle MP: It’s time to say thank you this Public Service Day

Taking time to say thank you is one of the hidden pillars of a society. Being on the receiving end of some “thanks” can make communit... more >
Nurses named as least-appreciated public sector workers

13/06/2019Nurses named as least-appreciated public sector workers

Nurses have been named as the most under-appreciated public sector professionals as new research reveals how shockingly under-vauled our NHS, edu... more >
Creating the Cardigan integrated care centre

10/06/2019Creating the Cardigan integrated care centre

Peter Skitt, county director and commissioner for Ceredigion Hywel Dda University Health Board, looks ahead to the new integrated care centre bei... more >

interviews

Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

24/10/2019Matt Hancock says GP recruitment is on the rise to support ‘bedrock of the NHS’

Today, speaking at the Royal College of General Practitioners (RCGP) annual conference, Matt Hancock highlighted what he believes to be the three... more >
NHS dreams come true for Teesside domestic

17/09/2019NHS dreams come true for Teesside domestic

Over 20 years ago, a Teesside hospital cleaner put down her mop and took steps towards her midwifery dreams. Lisa Payne has been delivering ... more >
How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

24/10/2018How can winter pressures be dealt with? Introduce a National Social Care Service, RCP president suggests

A dedicated national social care service could be a potential solution to surging demand burdening acute health providers over the winter months,... more >
RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

24/10/2018RCP president on new Liverpool college building: ‘This will be a hub for clinicians in the north’

The president of the Royal College of Physicians (RCP) has told NHE that the college’s new headquarters based in Liverpool will become a hu... more >

health service focus

View all News